In an end-stage renal disease patient starting dialysis, which laboratory value is most likely decreased and prompts intervention?

• A. Serum phosphate
• B. Serum potassium
• C. Serum magnesium
• D. Serum calcium

Answer: (D)

Calcium balance in end-stage renal disease is disrupted because the kidneys can’t activate vitamin D well, so calcium absorption from the gut drops. At the same time, phosphate isn’t cleared effectively, so phosphate levels rise and bind calcium, reducing the amount of free (ionized) calcium in the blood. This combination commonly lowers serum calcium, which signals the body to release parathyroid hormone and can lead to secondary hyperparathyroidism and bone disease if not addressed. That’s why a decreased calcium level is the lab finding that prompts intervention—clinicians will consider calcium-containing phosphate binders, vitamin D analogs, and adjustments to dialysate calcium or other therapies to raise calcium and control PTH. In contrast, potassium and phosphate levels are more typically elevated in ESRD and magnesium can vary, so they’re less likely to be the value that prompts the immediate intervention described here.